The partnership will result in the sharing of scientific knowledge, skills, research training and facilities with a common research purpose – the conduct of world-class translational cancer research and treatment.
The ONJCRI is based at Austin Health and is the successor to Melbourne's Ludwig Institute for Cancer Research. The collaboration will see La Trobe scientists work alongside Institute scientists and clinicians making available new discoveries and treatments for the benefit of cancer patients being treated there.
La Trobe University Vice-Chancellor Professor John Dewar welcomed the collaboration.
'La Trobe University is already home to some of the world's best scientists unravelling the molecular mechanisms behind diseases such as cancer and infectious conditions.
'We look forward to working with the team at the Olivia Newton-John Cancer Research Institute on the shared goal of making a difference on issues that matter,' Professor Dewar said.
The collaboration will lead to close interactions between scientists at both organisations, and include joint training of higher degree research students enrolled at the University.
In recognition of the Institute's reputation and research strength La Trobe has created a School of Cancer Medicine at the University.
It will be headed by the newly appointed Director of the ONJCRI, Professor Matthias Ernst.
The affiliation with the Olivia Newton-John Cancer Research Institute is aligned with the University's strategic plan to attract outstanding partners that build on the internationally recognised research strengths in biomedical and molecular science in La Trobe's $100 million LIMS Institute.
T 9479 6565
M 0418 964 325